Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Fortress Biotech, Inc. (NASDAQ: FBIO)
FBIO Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
225.70%
FBIO Stock Analysis
FBIO
PE Ratio:
0.8
FBIO
PEG Ratio:
Not Available
FBIO
Forward EPS Growth (12 month):
0.00%
FBIO
PS Ratio:
1.3
FBIO
PSG Ratio:
FBIO
Forward Revenue Growth (12 month):
40.50%
FBIO Articles
No data was found